Hyperforin analogues from St. John's Wort (Hypericum perforatum)

Journal of Natural Products

Volumn 63, Issue 3, 2000, Pages 412-415

  Verotta, Luisella ^a   Appendino, Giovanni ^b   Jakupovic, Jasmin ^c   Bombardelli, Ezio ^d  

^a Dipartimento di Chimica Organica e Industriale   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Analyticon Biotechnologies AG   (Germany)

^d INDENA S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; PHLOROGLUCINOL DERIVATIVE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG ISOLATION; DRUG STRUCTURE; HYPERICUM PERFORATUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ANALYSIS;

BICYCLO COMPOUNDS; HYPERICUM; MOLECULAR STRUCTURE; PHLOROGLUCINOL; PLANTS, MEDICINAL; SPECTRUM ANALYSIS; TERPENES;

HYPERICUM PERFORATUM; SAINT JOHNS WORT;

EID: 0034062571     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np9903752     Document Type: Article

References (16)

1. Bombardelli, E.; Morazzoni, P. Fitoterapia 1995, 66, 43-58.
2. Vitiello, B. J. Pharm. Pharmacol. 1999, 51, 513-517.
3. Bystrov, N. S.; Chernov, B. K.; Dobrynin, V. N.; Kolosov, M. N. Tetrahedron Lett. 1975, 16, 2791-2794. Revised configuration: Brondz, I.; Greibrokk, T.; Groth, P. A.; Aasen, A. J. Tetrahedron Lett. 1982, 23, 1299-1300. Absolute configuration: Brondz, I.; Greibrokk, T.; Groth, P.; Aasen, A. J. Acta Chem. Scand. A 1983, 37, 263-265.
4. Bystrov, N. S.; Chernov, B. K.; Dobrynin, V. N.; Kolosov, M. N. Tetrahedron Lett. 1975, 16, 2791-2794. Revised configuration: Brondz, I.; Greibrokk, T.; Groth, P. A.; Aasen, A. J. Tetrahedron Lett. 1982, 23, 1299-1300. Absolute configuration: Brondz, I.; Greibrokk, T.; Groth, P.; Aasen, A. J. Acta Chem. Scand. A 1983, 37, 263-265.
5. Bystrov, N. S.; Chernov, B. K.; Dobrynin, V. N.; Kolosov, M. N. Tetrahedron Lett. 1975, 16, 2791-2794. Revised configuration: Brondz, I.; Greibrokk, T.; Groth, P. A.; Aasen, A. J. Tetrahedron Lett. 1982, 23, 1299-1300. Absolute configuration: Brondz, I.; Greibrokk, T.; Groth, P.; Aasen, A. J. Acta Chem. Scand. A 1983, 37, 263-265.
6. (a) Erdelmeier, C. A. J. Pharmacopsychiatry 1998, 31 (Suppl. 1), 2-6.
7. (b) Chatterjee, S. S.; Noeldner, M.; Koch, E.; Erdelmeier, C. Pharmacopsychiatry 1998, 31 (Suppl. 1), 7-15.
8. (c) Chatterjee, S. S.; Bhattacharya, S. K.; Wonnemann, M.; Singer, A.; Müller, W. E. Life Sci. 1998, 63, 499-510.
9. Maisenbacher, P.; Kovar, K.-A. Planta Med. 1992, 58, 291-292.
10. Verotta, L.; Appendino, G.; Belloro, E.; Jakupovic, J.; Bombardelli, E.; Morazzoni, P. J. Nat. Prod. 1999, 62, 770-772.
11. Trifunovic, S.; Vajs, V.; Macura, S.; Juranic, N.; Djarmati, Z.; Jankov, R.; Milosavljevic, S. Photochemistry 1998, 49, 1305-1310.
12. Orth, H. C.; Hauer, H.; Erdelmeier, C. A. J.; Schmidt, P. C. Pharmazie 1999, 54, 76-77.
13. Rücker, G.; Manns, D.; Hartmann, R.; Bonsels, U. Arch. Pharm. (Wienheim) 1995, 328, 725-730.
14. Fukuyama, Y.; Kaneshi, A.; Tani, N.; Kodama, M. Phytochemistry 1993, 33, 483-485.
15. A full report on the degradation of hyperforin will be presented in the future.
16. Mennini, T. (Istituto di Ricerche Farmacologiche M. Negri, Milano, Italy). Personal communication.